OpenURL Connection Search

Select item for more details and to access through your institution.

89Zr-PET imaging to predict tumor uptake of 177Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10139-6
By:
- Giesen, Danique;
- Hooge, Marjolijn N. Lub-de;
- Nijland, Marcel;
- Heyerdahl, Helen;
- Dahle, Jostein;
- de Vries, Elisabeth G. E.;
- Pool, Martin
Publication type:
Article
Advances and challenges in immunoPET methodology.
Published in:
Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
By:
- Mohr, Philipp;
- van Sluis, Joyce;
- Hooge, Marjolijn N. Lub-de;
- Lammertsma, Adriaan A.;
- Brouwers, Adrienne H.;
- Tsoumpas, Charalampos
Publication type:
Article
Advances and challenges in immunoPET methodology.
Published in:
Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
By:
- Mohr, Philipp;
- van Sluis, Joyce;
- Hooge, Marjolijn N. Lub-de;
- Lammertsma, Adriaan A.;
- Brouwers, Adrienne H.;
- Tsoumpas, Charalampos
Publication type:
Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.241877
By:
- Suurs, Frans V.;
- Lorenczewski, Grit;
- Stienen, Sabine;
- Friedrich, Matthias;
- de Vries, Elisabeth G. E.;
- de Groot, Derk Jan A.;
- Hooge, Marjolijn N. Lub-de
Publication type:
Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.241877
By:
- Suurs, Frans V.;
- Lorenczewski, Grit;
- Stienen, Sabine;
- Friedrich, Matthias;
- de Vries, Elisabeth G. E.;
- de Groot, Derk Jan A.;
- Hooge, Marjolijn N. Lub-de
Publication type:
Article
89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922.
Published in:
Journal of Nuclear Medicine, 2010, v. 51, n. 5, p. 761, doi. 10.2967/jnumed.109.071043
By:
- Nagengast, Wouter B.;
- de Korte, Maarten A.;
- Munnink, Thijs H. Oude;
- Timmer-Bosscha, Hetty;
- den Dunnen, Wifred F.;
- Hollema, Harry;
- de Jong, Johan R.;
- Jensen, Michael R.;
- Quadt, Cornelia;
- Garcia-Echeverria, Carlos;
- van Dongen, Guus A. M. S.;
- Hooge, Marjolijn N. Lub-de;
- Schröder, Carolien P.;
- de Vries, Elisabeth G. E.
Publication type:
Article

Found: 6

<sup>89</sup>Zr-PET imaging to predict tumor uptake of <sup>177</sup>Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma.

Advances and challenges in immunoPET methodology.

Advances and challenges in immunoPET methodology.

Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.

Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.

<sup>89</sup>Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922.